• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Gastric acid-dependent diseases: a twentieth-century revolution.

作者信息

Sachs George, Shin Jai Moo, Munson Keith, Scott David R

机构信息

Department of Medicine, David Geffen School of Medicine, The Veterans Administration Greater Los Angeles Healthcare System, University of California at Los Angeles, Bldg 113, Rm 324 11301 Wilshire Blvd., Los Angeles, CA, 90073, USA,

出版信息

Dig Dis Sci. 2014 Jul;59(7):1358-69. doi: 10.1007/s10620-014-3104-8.

DOI:10.1007/s10620-014-3104-8
PMID:24852882
Abstract
摘要

相似文献

1
Gastric acid-dependent diseases: a twentieth-century revolution.胃酸依赖性疾病：一场二十世纪的革命。
Dig Dis Sci. 2014 Jul;59(7):1358-69. doi: 10.1007/s10620-014-3104-8.
2
Drugs for GERD and peptic ulcer disease.用于治疗胃食管反流病和消化性溃疡病的药物。
Med Lett Drugs Ther. 2018 Jan 15;60(1538):9-16.
3
Historical perspective of gastric acid inhibition.胃酸抑制的历史回顾。
Drugs. 2005;65 Suppl 1:1-6. doi: 10.2165/00003495-200565001-00002.
4
Comparison table: Drugs for GERD and peptic ulcer disease.比较表：用于胃食管反流病和消化性溃疡病的药物。
Med Lett Drugs Ther. 2018 Jan 15;60(1538):e16-e18.
5
Helicobacter pylori, acid, and omeprazole revisited: bacterial eradication and rebound hypersecretion.幽门螺杆菌、胃酸与奥美拉唑再探讨：细菌根除与胃酸分泌反跳性增高
Gastroenterology. 1999 Feb;116(2):479-83. doi: 10.1016/s0016-5085(99)70145-9.
6
Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.质子泵抑制剂在复杂性溃疡疾病和上消化道出血中的应用。
Am J Health Syst Pharm. 1999 Dec 1;56(23 Suppl 4):S5-11. doi: 10.1093/ajhp/56.suppl_4.S5.
7
[Prevention of bleeding recurrence in peptic ulcer by Helicobacter pylori eradication].[通过根除幽门螺杆菌预防消化性溃疡出血复发]
Gastroenterol Hepatol. 2005 Nov;28(9):567-75. doi: 10.1157/13080605.
8
Pathogenesis and treatment of acid peptic disorders: comparison of proton pump inhibitors with other antiulcer agents.酸性消化性疾病的发病机制与治疗：质子泵抑制剂与其他抗溃疡药物的比较
Clin Ther. 1996 Jan-Feb;18(1):2-34; discussion 1. doi: 10.1016/s0149-2918(96)80175-5.
9
Acid-related disorders in the elderly.老年人酸相关疾病。
Best Pract Res Clin Gastroenterol. 2009;23(6):839-48. doi: 10.1016/j.bpg.2009.10.004.
10
Effect of amoxicillin, clarithromycin, and rabeprazole, a new proton pump inhibitor, in eradication therapy for relapsing peptic ulcer diseases with Helicobacter pylori infection.阿莫西林、克拉霉素和新型质子泵抑制剂雷贝拉唑在根除幽门螺杆菌感染所致复发性消化性溃疡疾病治疗中的作用。
J Clin Gastroenterol. 2000 Dec;31(4):338-9. doi: 10.1097/00004836-200012000-00016.

引用本文的文献

1
RETRACTED: A Phase III Head-to-Head Study to Compare the Efficacy and Safety of Fexuprazan and Esomeprazole in Treating Patients with Erosive Esophagitis.撤回：一项比较非布司他和埃索美拉唑治疗糜烂性食管炎疗效和安全性的III期头对头研究。
J Clin Med. 2024 May 31;13(11):3262. doi: 10.3390/jcm13113262.
2
Bioinformatic Study of Possible Acute Regulation of Acid Secretion in the Stomach.胃酸分泌的可能急性调控的生物信息学研究。
J Membr Biol. 2024 Apr;257(1-2):79-89. doi: 10.1007/s00232-024-00310-7. Epub 2024 Mar 4.
3
Electrostatic switch mechanisms of membrane protein trafficking and regulation.

本文引用的文献

1
The rediscovery of H. pylori bacteria in the gastric mucosa by Robin Warren, and implications of this finding for human biology and disease.罗宾·沃伦在胃黏膜中重新发现幽门螺杆菌及其这一发现对人类生物学和疾病的影响。
Dig Dis Sci. 2013 Nov;58(11):3072-8. doi: 10.1007/s10620-013-2863-y.
2
Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6.奥美拉唑增强了 TRPM6 镁转运体在结肠中的表达。
Pflugers Arch. 2013 Nov;465(11):1613-20. doi: 10.1007/s00424-013-1306-0. Epub 2013 Jun 12.
3
Independent trafficking of the KCNQ1 K+ channel and H+-K+-ATPase in gastric parietal cells from mice.
膜蛋白运输与调控的静电开关机制
Biophys Rev. 2023 Dec 6;15(6):1967-1985. doi: 10.1007/s12551-023-01166-2. eCollection 2023 Dec.
4
Assessments of CYP‑inhibition‑based drug-drug interaction between vonoprazan and poziotinib and .评估 vonoprazan 与 poziotinib 及. 基于 CYP 抑制的药物相互作用。
Pharm Biol. 2023 Dec;61(1):356-361. doi: 10.1080/13880209.2023.2173253.
5
A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases: A systematic review and meta-analysis.钾离子竞争性酸阻滞剂与质子泵抑制剂治疗胃酸相关疾病的疗效和安全性比较：系统评价和荟萃分析。
J Gastroenterol Hepatol. 2022 Dec;37(12):2217-2228. doi: 10.1111/jgh.16017. Epub 2022 Oct 26.
6
An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19.关于质子泵抑制剂作为2019冠状病毒病风险因素的另一种观点
Clin Drug Investig. 2021 Mar;41(3):287-289. doi: 10.1007/s40261-021-01007-8. Epub 2021 Feb 19.
7
Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.Vonoprazan 与质子泵抑制剂治疗胃食管反流病的疗效和安全性的直接比较：系统评价和荟萃分析。
Dig Dis Sci. 2021 Jan;66(1):19-28. doi: 10.1007/s10620-020-06141-5. Epub 2020 Feb 24.
8
Proton Pump Inhibitors and Kidney Disease - GI Upset for the Nephrologist?质子泵抑制剂与肾脏疾病——肾脏病医生面临的胃肠道不适问题？
Kidney Int Rep. 2017 May;2(3):297-301. doi: 10.1016/j.ekir.2017.01.005. Epub 2017 Jan 23.
9
Radiographic Localization Study of a Novel Potassium-Competitive Acid Blocker, Vonoprazan, in the Rat Gastric Mucosa.新型钾离子竞争性酸阻滞剂沃克在大鼠胃黏膜中的影像学定位研究
Dig Dis Sci. 2016 Jul;61(7):1888-94. doi: 10.1007/s10620-016-4100-y. Epub 2016 Mar 9.
10
Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders.难治性功能性胃肠病患者的小肠细菌过度生长
J Neurogastroenterol Motil. 2016 Jan 31;22(1):60-8. doi: 10.5056/jnm15116.
小鼠壁细胞中 KCNQ1 K+ 通道和 H+-K+-ATPase 的独立转运。
Am J Physiol Gastrointest Liver Physiol. 2013 Jan 15;304(2):G157-66. doi: 10.1152/ajpgi.00346.2012. Epub 2012 Nov 15.
4
The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin.酸度变化对幽门螺杆菌生长和氨苄西林杀菌效果的影响。
Aliment Pharmacol Ther. 2012 Nov;36(10):972-9. doi: 10.1111/apt.12059. Epub 2012 Sep 25.
5
Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting System.奥美拉唑和埃索美拉唑相关低镁血症：FDA 不良事件报告系统公开版本的数据挖掘。
Int J Med Sci. 2012;9(5):322-6. doi: 10.7150/ijms.4397. Epub 2012 Jun 13.
6
Helicobacter pylori: Eradication or Preservation.幽门螺杆菌：根除还是保留。
F1000 Med Rep. 2012;4:7. doi: 10.3410/M4-7. Epub 2012 Apr 2.
7
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.幽门螺杆菌感染的管理——马斯特里赫特 IV/佛罗伦萨共识报告。
Gut. 2012 May;61(5):646-64. doi: 10.1136/gutjnl-2012-302084.
8
Characterization of a novel potassium-competitive acid blocker of the gastric H,K-ATPase, 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438).一种新型钾竞争性酸阻滞剂的表征，即 1-[5-(2-氟苯基)-1-(吡啶-3-基磺酰基)-1H-吡咯-3-基]-N-甲基甲胺单富马酸盐（TAK-438）。
J Pharmacol Exp Ther. 2011 Nov;339(2):412-20. doi: 10.1124/jpet.111.185314. Epub 2011 Aug 9.
9
Structure of the human histamine H1 receptor complex with doxepin.人源组胺 H1 受体复合物与多塞平的结构。
Nature. 2011 Jun 22;475(7354):65-70. doi: 10.1038/nature10236.
10
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.铋钾柠檬酸胶囊、甲硝唑和四环素三联疗法联合奥美拉唑与克拉霉素三联疗法根除幽门螺杆菌的随机、开放、非劣效性、3 期临床试验。
Lancet. 2011 Mar 12;377(9769):905-13. doi: 10.1016/S0140-6736(11)60020-2. Epub 2011 Feb 21.